These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10096531)

  • 21. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of long-term allograft survival in 632 CyA-treated recipients of a primary renal transplant.
    Montagnino G; Tarantino A; Cesana B; Rossini G; Da Milano I; Arodi A; Elli A; Ponticelli C
    Transpl Int; 1997; 10(4):268-75. PubMed ID: 9249936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study.
    Dudley C; Pohanka E; Riad H; Dedochova J; Wijngaard P; Sutter C; Silva HT;
    Transplantation; 2005 Feb; 79(4):466-75. PubMed ID: 15729174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V; Rice JC; Carson RW; Gugliuzza KK; Fish JC
    Clin Transplant; 1996 Apr; 10(2):203-8. PubMed ID: 8664520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
    Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
    Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.
    Nainani N; Patel N; Tahir N; Kumar R; Weber-Shrikant E; Gundroo AA; Murray BM; Tornatore KM; Blessios GA; Venuto RC
    Nephrol Dial Transplant; 2012 May; 27(5):2077-83. PubMed ID: 22058172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of allograft biopsy specimens from long-term surviving patients with stable renal function: predictive value of long-term graft prognosis.
    Toki K; Takahara S; Moriyama T; Kyo M; Morozumi K; Yazawa K; Tanaka T; Wang JD; Permpongkosol S; Kokado Y; Okuyama A
    Clin Transplant; 2002; 16 Suppl 8():24-30. PubMed ID: 12464128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerulonephritis is the major cause of proteinuria in renal transplant recipients: histopathologic findings of renal allografts with proteinuria.
    Chung J; Park SK; Park JS; Kim SC; Han DJ; Yu E
    Clin Transplant; 2000 Oct; 14(5):499-504. PubMed ID: 11048996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of needle renal allograft biopsy. III. A prospective study.
    Matas AJ; Tellis VA; Sablay L; Quinn T; Soberman R; Veith FJ
    Surgery; 1985 Nov; 98(5):922-6. PubMed ID: 3904051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
    Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
    Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of 1- and 3-month protocol biopsies on renal allograft function: a randomized controlled study.
    Kurtkoti J; Sakhuja V; Sud K; Minz M; Nada R; Kohli HS; Gupta KL; Joshi K; Jha V
    Am J Transplant; 2008 Feb; 8(2):317-23. PubMed ID: 18093273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M; Nitschke M; Weidtmann B; Jabs WJ; Wong W; Suefke S; Steinhoff J; Fricke L
    Transplantation; 2006 Apr; 81(7):1035-40. PubMed ID: 16612281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
    Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
    Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.